09:55 AM EDT, 07/18/2025 (MT Newswires) -- ARS Pharmaceuticals ( SPRY ) said Friday that the UK Medicines and Healthcare products Regulatory Agency has approved EURneffy adrenaline nasal spray as an emergency treatment of anaphylaxis.

The approval allows the use of nasal spray in adults and children weighing at least 30 kilograms, providing patients with a needle-free option, the company said.

Price: 18.38, Change: +0.03, Percent Change: +0.16